US4053626A
(en)
*
|
1973-03-13 |
1977-10-11 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Cholesterol level-lowering phenoxyacetic acids
|
ATE275959T1
(de)
|
1992-05-19 |
2004-10-15 |
Graham Edmund Kelly |
Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
|
US5446061A
(en)
*
|
1993-11-05 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
US5407955A
(en)
*
|
1994-02-18 |
1995-04-18 |
Eli Lilly And Company |
Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
|
US5446071A
(en)
*
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
CA2208859A1
(en)
*
|
1995-01-13 |
1996-07-18 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment
|
BE1010487A6
(nl)
|
1996-06-11 |
1998-10-06 |
Unilin Beheer Bv |
Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
|
AUPO203996A0
(en)
*
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
ZA979646B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
ZA979647B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
US5994390A
(en)
*
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
ZA979644B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
JP2001502709A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患または症候群の予防または治療に有用な新規なシス―3,4―クロマン誘導体
|
US5958967A
(en)
*
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6043269A
(en)
*
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
WO1998018773A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
CA2269936A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Lise Brown Christiansen |
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
EP0937062B1
(en)
*
|
1996-10-28 |
2002-12-11 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5919817A
(en)
*
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
EP0937057B1
(en)
*
|
1996-10-28 |
2003-01-15 |
Novo Nordisk A/S |
Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
EP0934299A1
(en)
*
|
1996-10-28 |
1999-08-11 |
Novo Nordisk A/S |
NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
|
US5985306A
(en)
*
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
US6146668A
(en)
|
1997-04-28 |
2000-11-14 |
Novogen, Inc. |
Preparation of isoflavones from legumes
|
NZ527735A
(en)
*
|
1997-05-01 |
2005-10-28 |
Novogen Inc |
Treatment or prevention of menopausal symptoms and osteoporosis
|
AUPP112497A0
(en)
*
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
AUPP260798A0
(en)
|
1998-03-26 |
1998-04-23 |
Novogen Research Pty Ltd |
Treatment of medical related conditions with isoflavone containing extracts of clover
|
KR20000001793A
(ko)
*
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
AUPP868599A0
(en)
*
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
US20090233999A1
(en)
*
|
1999-09-06 |
2009-09-17 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ266199A0
(en)
*
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ520300A0
(en)
*
|
2000-01-21 |
2000-02-17 |
Novogen Research Pty Ltd |
Food product and process
|
EP1282615B1
(en)
*
|
2000-03-01 |
2011-10-19 |
N.V. Organon |
Chroman derivatives as estrogenic compounds
|
AUPR363301A0
(en)
*
|
2001-03-08 |
2001-04-05 |
Novogen Research Pty Ltd |
Dimeric isoflavones
|
US20050119301A1
(en)
*
|
2001-03-16 |
2005-06-02 |
Alan Husband |
Treatment of restenosis
|
AU2004290613B2
(en)
*
|
2003-11-18 |
2010-03-25 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
EP1685140A4
(en)
*
|
2003-11-18 |
2009-02-25 |
Novogen Res Pty Ltd |
PRODRUGS BASED ON ISOFLAVONOIDS, COMPOSITIONS THEREOF AND THERAPEUTIC PROCESSES INVOLVING THEM
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
CN101056868B
(zh)
|
2004-09-21 |
2012-05-02 |
马休爱德华兹股份有限公司 |
取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
|
CA2816319C
(en)
|
2010-11-01 |
2020-06-30 |
Marshall Edwards, Inc. |
Isoflavonoid compounds and methods for the treatment of cancer
|
HUE054998T2
(hu)
|
2015-02-02 |
2021-10-28 |
Mei Pharma Inc |
Kombinációs terápiák emlõrák kezelésében való alkalmazásra
|